Kura Oncology (KURA) Stock Price, Quote, News & History | Benzinga

Kura Oncology Inc (KURA) Stock Price, Quote, News & History

KURANASDAQ

Trade with Public

Trade with Public

$9.26

-0.01-0.11%

At close: Apr 24, 5:00 PM EST

$9.28

0.020.22%

After Hours: 5:35 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$9.34

Close

$9.26

Volume / Avg.

852.93K / 1.47M

Day Range

$9.08 - $9.38

52 Wk Range

5.45 - 12.49

Market Cap

$823.72M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

16.43%

Days to Cover

10.98

Recent Kura Oncology Inc News

Kura Oncology Advances Kidney Cancer Program With Solid Early-Stage Results

Kura Oncology says kidney cancer trial data shows 44% response rate and strong disease control; analysts maintain Buy ratings.

Vandana Singh

Kura Scores A Big Win As FDA Approves Its New Leukemia Pill

Komzifti wins full FDA approval for NPM1-mutated AML, supported by KOMET-001 data, as Wedbush boosts Kura Oncology's price target to $38.

Vandana Singh

Kura Oncology Scores $30 Million Boost As New Leukemia Drug Enters Major Trial

Kura Oncology rises after $30M milestone from Kyowa Kirin; Phase 3 ziftomenib dosing and FTI data at ESMO bolster pipeline.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-64.06M

Investing Cash Flow (TTM)

-13.10M

Financing Cash Flow (TTM)

1.79M

Free Cash Flow (TTM)

-70.70M

Capital Expenditure (TTM)

-6.64M

Net Change in Cash (TTM)

-75.36M

Analyst Trends and Forecast

3

Nov 25

2

Jan

3

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$176.05M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

12.07

PB Ratio (TTM)

4.74

Earnings Yield % (TTM)

-34.23%

Earnings Yield % (FWD)

-25.24%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.96

Company Debt

Total Debt

$9.71M

LT Debt

$9.71M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$149.10M

Debt to Equity

0.12

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$9.34

Close

$9.26

Volume / Avg.

852.93K / 1.47M

Day Range

$9.08 - $9.38

52 Wk Range

5.45 - 12.49

Market Cap

$823.72M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

16.43%

Days to Cover

10.98

About

Sector

Health Care

Industry

Biotechnology

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathway...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kura Oncology (KURA) stock?

A

You can purchase shares of Kura Oncology (NASDAQ:KURA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kura Oncology (KURA) competitors?

A

There are no as such competitors for Kura Oncology.

Q

What is the forecast, or price target, for Kura Oncology (KURA) stock?

A

Kura Oncology has a consensus price target of $24.56.

Q

What is the current price for Kura Oncology (KURA)?

A

The stock price for Kura Oncology (NASDAQ: KURA) is $9.28 last updated April 24, 2026 at 5:35 PM EDT.

Q

Does Kura Oncology (KURA) pay a dividend?

A

There are no upcoming dividends for Kura Oncology.

Q

When is Kura Oncology (NASDAQ:KURA) reporting earnings?

A

Kura Oncology does not have any upcoming earnings scheduled.

Q

Is Kura Oncology (KURA) going to split?

A

There is no upcoming split for Kura Oncology.

Q

What sector and industry does Kura Oncology (KURA) operate in?

A

Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.